Introduction
Introduction Statistics Contact Development Disclaimer Help
DTIC ADA621368: Antibodies Expressed by Intratumoral B Cells as the...
by Defense Technical Information Center
Thumbnail
Download
Web page
As described in our Annual Report, our initial work
focused on the expression, purification, and
characterization of monoclonal antibodies (mAbs) cloned
from intratumoral B lymphocytes (ITLs). While this work
was successful in identifying a mAb with preferential
binding to tropomyosin 4, all cloned mAbs exhibited
polyreactivity. This suggested that the isolated ITLs
that we used for mAb production were not members of
clonal B cell populations arising in response to
stimulation by intratumoral antigens. Hence, our most
recent efforts have focused on methods to permit the
cloning and expression of recombinant antibodies
specifically from oligoclonal ITLs. We accomplished this
by performing deep sequencing of VH and VL Ig genes from
ITLs from seven additional lung cancer patients, We
identified a total of 155,901 functional VH gene
sequences with individual patient samples containing from
3,327 to 77,182 functional sequences. Although we
obtained evidence for somatic hypermutation among these
sequences, we did not identify any dominant clones.
Sequences representing all VH gene families were
identified and exhibited a distribution typically found
in peripheral B cells. This suggests that it may be
necessary to sequence Ig genes from microdissected
intratumoral germinal centers in order to identify clonal
ITL populations.
Date Published: 2018-11-02 01:32:15
Identifier: DTIC_ADA621368
Item Size: 7932767
Language: english
Media Type: texts
# Topics
DTIC Archive; ; DUKE UNIV DURHAM NC; ...
# Collections
dticarchive
additional_collections
# Uploaded by
@chris85
# Similar Items
View similar items
PHAROS
You are viewing proxied material from tilde.pink. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.